|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net earnings (loss) | |||||
| Depreciation, depletion and amortization | |||||
| Impairments | |||||
| Accretion of asset retirement obligation | |||||
| Deferred income taxes | |||||
| Unrealized (gain) loss on risk management | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Foreign exchange (gain) loss on settlements | |||||
| Other | |||||
| Net change in other assets and liabilities | |||||
| Net change in non-cash working capital | |||||
| Cash From (Used in) Operating Activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Acquisitions | |||||
| Corporate acquisition, net of cash acquired | |||||
| Proceeds from divestitures | |||||
| Net change in investments and other | |||||
| Cash From (Used in) Investing Activities | |||||
| Financing Activities | |||||
| Net issuance (repayment) of revolving debt | |||||
| Issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Purchase of shares of common stock | |||||
| Dividends on shares of common stock | |||||
| Other | |||||
| Cash From (Used in) Financing Activities | |||||
| Foreign Exchange Gain (Loss) on Cash, Cash Equivalents and Restricted Cash Held in Foreign Currency | |||||
| Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | |||||
| Cash, Cash Equivalents and Restricted Cash, Beginning of Year | |||||
| Cash, Cash Equivalents and Restricted Cash, End of Year | |||||
| Cash, End of Year | |||||
| Cash Equivalents, End of Year | |||||
| Restricted Cash, End of Year | |||||
Loading...